@madamswer
@Fire Bull is right
Since DH16 there has been a change in the revenue model and you can see the drop in cost of revenue from 55% to 35% over the last 2 years. The inverse is obviously the gross margin (see below)
Column 1 Column 2 Column 3 Column 4 Column 5 Column 6 Column 7 Column 8 Column 9 Column 10 Column 11 0 2012 2013 2014 2015 DH16 JH16 2016 DH 17 JH17 2017 1 revenue 7.912 9.644 12.572 14.893 7.634 6.935 14.569 6.45 7.057 13.507 2 NPAT 0.168 0.374 0.703 1.256 0.223 0.887 1.11 0.628 0.707 1.335 3 EBITDA 0.842 1.172 1.627 2.032 0.511 1.6 2.111 1.19 1.446 2.636 4 D&A 0.196 0.179 0.368 0.372 0.213 0.23 0.443 0.303 0.47 0.773 5 Interest 0.43 0.469 0.195 0.113 0.037 0.032 0.069 0.02 0.048 0.068 6 Interest income 0.003 0.002 0.003 -0.003 0.001 -0.001 7 PBT 0.219 0.526 1.064 1.547 0.264 1.335 1.599 0.868 0.927 1.795 8 Tax 0.051 0.152 0.332 0.468 0.041 0.355 0.396 0.24 0.119 0.359 9 Reconciliation 0.029 -0.177 0.093 0.101 0.101 10 Other income 0.03 11 12 EBITDA margin 11% 12% 13% 14% 7% 23% 14% 18% 20% 20% 13 NPAT margin 2% 4% 6% 8% 3% 13% 8% 10% 10% 10% 14 15 16 Expenses 17 COGS -3.644 -5.007 -7.043 -8.012 -4.181 -2.854 -7.035 -2.592 -2.438 -5.03 18 % rev 46% 52% 56% 54% 55% 41% 48% 40% 35% 37% 19 Employee -1.782 -1.848 -2.252 -2.667 -1.452 -1.267 -2.719 -1.43 -1.476 -2.906 20 23% 19% 18% 18% 19% 18% 19% 22% 21% 22% 21 Marketing -0.124 -0.198 -0.187 -0.407 -0.177 -0.329 -0.506 -0.31 -0.6 -0.91 22 2% 2% 1% 3% 2% 5% 3% 5% 9% 7% 23 G&A -1.069 -1.072 -1.062 -1.456 -1.049 -0.628 -1.677 -0.727 -0.844 -1.571 24 14% 11% 8% 10% 14% 9% 12% 11% 12% 12% 25 Merchandise -0.409 -0.418 -0.436 -0.379 -0.203 -0.179 -0.382 -0.158 -0.168 -0.326 26 5% 4% 3% 3% 3% 3% 3% 2% 2% 2% 27 D&A -0.196 -0.179 -0.368 -0.372 -0.213 -0.23 -0.443 -0.303 -0.47 -0.773 28 2% 2% 3% 2% 3% 3% 3% 5% 7% 6% 29 Other -0.039 -0.002 -0.058 -0.081 -0.139 -0.042 -0.086 -0.128 30 0% 0% 0% 0% 1% 1% 1% 1% 1% 1% 31 Finance -0.43 -0.469 -0.195 -0.113 -0.037 -0.032 -0.069 -0.02 -0.048 -0.068 32 5% 5% 2% 1% 0% 0% 0% 0% 1% 1%
- Forums
- ASX - By Stock
- KME
- Ann: Appendix 4E and 30 June 2017 Annual Report
Ann: Appendix 4E and 30 June 2017 Annual Report, page-23
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add KME (ASX) to my watchlist
(20min delay)
|
|||||
Last
48.0¢ |
Change
0.025(5.49%) |
Mkt cap ! $27.00M |
Open | High | Low | Value | Volume |
46.0¢ | 48.5¢ | 46.0¢ | $24.25K | 51.57K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 5000 | 46.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
48.0¢ | 1739 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 439 | 0.915 |
1 | 7582 | 0.910 |
1 | 5524 | 0.905 |
2 | 20484 | 0.900 |
1 | 1149 | 0.870 |
Price($) | Vol. | No. |
---|---|---|
0.945 | 557 | 1 |
0.950 | 12474 | 2 |
0.960 | 53883 | 2 |
0.970 | 20668 | 1 |
0.980 | 27357 | 2 |
Last trade - 14.10pm 25/11/2024 (20 minute delay) ? |
Featured News
KME (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online